BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,324,000 | -34.8% | 43,990 | -24.4% | 0.08% | -17.4% |
| Q2 2020 | $3,564,000 | +151.7% | 58,153 | +132.4% | 0.09% | +148.6% |
| Q1 2020 | $1,416,000 | -5.9% | 25,025 | -5.3% | 0.04% | +76.2% |
| Q4 2019 | $1,505,000 | -18.1% | 26,427 | -23.0% | 0.02% | -4.5% |
| Q3 2019 | $1,837,000 | +323.3% | 34,317 | +372.2% | 0.02% | +175.0% |
| Q2 2019 | $434,000 | – | 7,267 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |